User profiles for K. CALLIS-DUFFIN
 | Kristina DuffinProfessor and Chair, Department of Dermatology, University of Utah Verified email at hsc.utah.edu Cited by 10737 |
[HTML][HTML] Phase 3 studies comparing brodalumab with ustekinumab in psoriasis
…, L Kircik, S Chimenti, K Callis Duffin… - … England Journal of …, 2015 - Mass Medical Soc
Background Early clinical studies suggested that the anti–interleukin-17 receptor A monoclonal
antibody brodalumab has efficacy in the treatment of psoriasis. Methods In two phase 3 …
antibody brodalumab has efficacy in the treatment of psoriasis. Methods In two phase 3 …
[HTML][HTML] Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021
…, N Corp, H Bertheussen, K Callis Duffin… - Nature Reviews …, 2022 - nature.com
Since the second version of the Group for Research and Assessment of Psoriasis and
Psoriatic Arthritis (GRAPPA) treatment recommendations were published in 2015, therapeutic …
Psoriatic Arthritis (GRAPPA) treatment recommendations were published in 2015, therapeutic …
[PDF][PDF] Genome-wide association analysis of psoriatic arthritis and cutaneous psoriasis reveals differences in their genetic architecture
…, E Ellinghaus, V Chandran, K Callis-Duffin… - The American Journal of …, 2015 - cell.com
Psoriasis vulgaris (PsV) is a common inflammatory and hyperproliferative skin disease. Up
to 30% of people with PsV eventually develop psoriatic arthritis (PsA), an inflammatory …
to 30% of people with PsV eventually develop psoriatic arthritis (PsA), an inflammatory …
The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project)
…, DD Gladman, GG Kreuger, K Callis-Duffin… - Annals of the …, 2013 - ard.bmj.com
Objective To develop new composite disease activity indices for psoriatic arthritis (PsA).
Methods Data from routine clinic visits at multiple centres were collected in a systematic manner. …
Methods Data from routine clinic visits at multiple centres were collected in a systematic manner. …
[HTML][HTML] Multiple Loci within the major histocompatibility complex confer risk of psoriasis
…, GR Abecasis, XJ Zhang, KP Callis-Duffin… - PLoS …, 2009 - journals.plos.org
Psoriasis is a common inflammatory skin disease characterized by thickened scaly red
plaques. Previously we have performed a genome-wide association study (GWAS) on psoriasis …
plaques. Previously we have performed a genome-wide association study (GWAS) on psoriasis …
Efficacy and safety of ixekizumab in a randomized, double‐blinded, placebo‐controlled phase IIIb study of patients with moderate‐to‐severe genital psoriasis
…, AB Gottlieb, JF Merola, K Callis Duffin… - British journal of …, 2018 - academic.oup.com
Background Genital psoriasis (GenPs) is a common, debilitating and difficult‐to‐treat
manifestation of plaque psoriasis. However, few controlled, interventional studies of GenPs exist. …
manifestation of plaque psoriasis. However, few controlled, interventional studies of GenPs exist. …
[HTML][HTML] Genetic signature to provide robust risk assessment of psoriatic arthritis development in psoriasis patients
Psoriatic arthritis (PsA) is a complex chronic musculoskeletal condition that occurs in ~30%
of psoriasis patients. Currently, no systematic strategy is available that utilizes the differences …
of psoriasis patients. Currently, no systematic strategy is available that utilizes the differences …
Patient satisfaction with treatments for moderate‐to‐severe plaque psoriasis in clinical practice
K Callis Duffin, H Yeung, J Takeshita… - British Journal of …, 2014 - academic.oup.com
Background Treatment satisfaction among patients with moderate‐to‐severe psoriasis has
not been studied and compared across treatments using a validated instrument. Objectives …
not been studied and compared across treatments using a validated instrument. Objectives …
Group for research and assessment of psoriasis and Psoriatic arthritis/outcome measures in rheumatology consensus‐based recommendations and research agenda …
…, WH Boehncke, K Callis Duffin… - Arthritis & …, 2018 - Wiley Online Library
… Merola,3 Josef Smolen,4 Leonieke JJ van Mens,5 Heidi Bertheussen,6 Wolf-Henning
Boehncke,7 Kristina Callis Duffin,8 … Callis Duffin has received consulting fees, speaking fees, and/ …
Boehncke,7 Kristina Callis Duffin,8 … Callis Duffin has received consulting fees, speaking fees, and/ …
[HTML][HTML] Carriers of rare missense variants in IFIH1 are protected from psoriasis
…, BJ Feng, A Poon, KP Callis-Duffin… - Journal of investigative …, 2010 - Elsevier
Testing of ∼25,000 putative functional single-nucleotide polymorphisms (SNPs) across the
human genome in a genetic association study has identified three psoriasis genes, IL12B, …
human genome in a genetic association study has identified three psoriasis genes, IL12B, …